(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Gel Electrophoresis - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global gel electrophoresis market was valued at US$1.5 billion in 2025 and is projected to reach US$2 billion by 2032, expanding at a compound annual growth rate (CAGR) of 4.1%. Market growth is being supported by rising demand for molecular diagnostics, continued investment in genomics and proteomics, and the adoption of automated, high-throughput laboratory technologies.
Gel Electrophoresis Market Trends and Growth Drivers
Gel electrophoresis remains central to DNA, RNA and protein analysis across academic research, clinical diagnostics, biotechnology, pharmaceutical development and forensic science. Its established role in polymerase chain reaction validation, restriction enzyme analysis, genetic mapping, sequencing workflows, protein characterization and biomarker research continues to sustain demand across laboratories worldwide.
Expanding applications in molecular diagnostics represent a major market driver. The increasing prevalence of genetic disorders, cancer and infectious diseases is accelerating the use of analytical technologies that support mutation detection, pathogen identification and disease monitoring. Gel electrophoresis also contributes to personalized medicine by enabling researchers and clinicians to examine genetic variants, protein expression patterns and disease-associated biomarkers.
Growth in genomics and proteomics is further strengthening the market outlook. Research programs focused on gene expression, molecular pathways, therapeutic targets and protein function require reliable separation and visualization technologies. Pharmaceutical and biotechnology companies use gel electrophoresis in drug discovery, quality assessment, protein purity analysis and the investigation of disease mechanisms.
Technology Innovation Improves Laboratory Performance
Technological advances are increasing the speed, consistency and analytical performance of gel electrophoresis workflows. Automated electrophoresis platforms integrate sample handling, separation, imaging and data analysis, reducing manual intervention while improving laboratory throughput and reproducibility.
Precast and gradient gels are also gaining adoption because they offer standardized composition, consistent performance and shorter preparation times. Improvements in gel chemistry support enhanced resolution and more efficient separation across a wider range of molecular sizes. Advanced fluorescent stains provide greater sensitivity for detecting low concentrations of nucleic acids and proteins, while reducing reliance on traditional staining agents.
Temperature-controlled systems, optimized buffers and digital imaging technologies are further improving biomolecule stability and analytical reliability. Collectively, these innovations are broadening the use of gel electrophoresis in molecular diagnostics, next-generation research workflows, drug development and clinical laboratory applications.
Market Segment and Regional Outlook
The report analyzes the global gel electrophoresis market by end use, including laboratory research, pharmaceutical and biotechnology companies, and other end-use categories. The laboratory research segment is forecast to reach US$951.1 million by 2032, advancing at a CAGR of 4.1%. The pharmaceutical and biotechnology companies segment is projected to expand at a CAGR of 4.5% during the analysis period.
Geographic coverage includes the United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The U.S. gel electrophoresis market was valued at US$403.5 million in 2025. China is forecast to grow at a CAGR of 7.1% and reach US$402.2 million by 2032, reflecting expanding life sciences research, healthcare investment and biotechnology capacity.
The regional analysis also examines France, Germany, Italy, the United Kingdom, Spain, Russia, Australia, India, South Korea, Argentina, Brazil, Mexico, Iran, Israel, Saudi Arabia and the United Arab Emirates, along with other major regional markets.
Report Scope and Strategic Value
The gel electrophoresis market report provides independent annual sales analysis and forecasts from 2025 through 2032. It evaluates market trends, growth drivers, restraints, segment performance, regional opportunities and competitive conditions. The research is designed to support strategic planning, investment evaluation, product development and market-entry decisions.
Detailed analysis of the global gel electrophoresis market by end use and geography Market forecasts presented in US$ million for the 2025-2032 period Assessment of molecular diagnostics, genomics, proteomics and personalized medicine trends Evaluation of automation, precast gels, fluorescent staining and imaging technologies Regional analysis covering established and emerging life sciences markets Competitive intelligence and profiles of participating companies One year of complimentary report updates
Companies Featured in the Gel Electrophoresis Market Report
AB Sciex LLC Agilent Technologies, Inc. Bio-Rad Laboratories, Inc. Harvard Bioscience, Inc. Helena Laboratories Corporation Hoefer, Inc. Lonza Group AG PerkinElmer U.S. LLC SERVA Electrophoresis GmbH Shimadzu Corporation
Domain Expert Insights and Market Intelligence
The report incorporates perspectives from domain experts across industry, enterprise and academia, adding strategic context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, corporate activity, scientific conferences, keynote presentations, panel sessions, company disclosures, annual reports, institutional publications and other validated sources.
These insights are synthesized to identify the direction of the gel electrophoresis market, the forces influencing adoption and the developments most likely to affect competitive strategy. The analysis also extends beyond broad global market share estimates by examining regional competitive structures where relevant. This approach provides a more precise view of company positioning, geographic variation and market opportunities across research, pharmaceutical, biotechnology and diagnostic applications.
As investment in molecular biology, precision medicine and life sciences infrastructure continues, gel electrophoresis is expected to retain an important role in laboratory research and clinical analysis. Automation, improved consumables and more sensitive detection technologies will remain central to future market expansion through 2032.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment